Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats

Journal of Nutritional Biochemistry

Volumn 23, Issue 3, 2012, Pages 252-264

  Chen, Wen Ying ^a   Lin, Shih Yi ^a   Pan, Hung Chuan ^a   Liao, Su Lan ^a   Chuang, Yu Han ^a   Yen, Yu Ju ^a   Lin, Szu Yin ^a   Chen, Chun Jung ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Cholestasis; DHA; Fibrosis; Inflammation; Oxidative stress

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; DOCOSAHEXAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; SMAD2 PROTEIN; SMAD3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BILE DUCT LIGATION; CONTROL GROUP; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HISTOPATHOLOGY; INTRAHEPATIC CHOLESTASIS; LEUKOCYTE; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; RAT; REDOX STRESS; SUPPLEMENTATION;

ANIMALS; BILE DUCTS; CHOLESTASIS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROSIS; INTERLEUKIN-1BETA; LIGATION; LIVER; LIVER DISEASES; MALE; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 82955209058     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.11.022     Document Type: Article

References (77)

1. Trauner M., Meierer P.J., Boyer J.L. Molecular pathogenesis of cholestasis. N Eng J Med 1998, 39:1217-1227.
2. Guicciardi M.E., Gores G.J. Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease. Dig Liver Dis 2002, 34:387-392.
3. Bataller R., Brenner D.A. Liver fibrosis. J Clin Invest 2005, 115:209-218.
4. Greim H., Trulzsch D., Roboz J., Dressler K., Czygan P., Hutterer F., et al. Mechanism of cholestasis. Bile acids in normal rat livers and in those after bile duct ligation. Gastroenterology 1972, 63:837-845.
5. Desmet V., Roskams T., Van Eyken P. Ductular reaction in the liver. Pathol Res Pract 1995, 191:513-524.
6. Fox E.S., Kim J.C., Tracy T.F. NF-kappaB activation and modulation in hepatic macrophages during cholestatic injury. J Surg Res 1997, 72:129-134.
7. Kawamura K., Kobayashi Y., Kageyama F., Kawasaki T., Nagasawa M., Toyokuni S., et al. Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis. Am J Gastroenterol 2000, 95:3596-3601.
8. Liu T.Z., Lee K.T., Chern C.L., Cheng J.T., Stern A., Tsai L.Y. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. Ann Clin Lab Sci 2001, 31:383-390.
9. Lamireau T., Zoltowska M., Levy E., Yousef I., Rosenbaum J., Tuchweber B., et al. Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. Life Sci 2003, 72:1401-1411.
10. Gäbele E., Froh M., Arteel G.E., Uesugi T., Hellerbrand C., Schölmerich J., et al. TNFα is required for cholestasis-induced liver fibrosis in the mouse. Biochem Biophys Res Commun 2009, 378:348-353.
11. Nishitani Y., Okazaki S., Imabayashi K., Katada R., Umetani K., Yajima H., et al. Saturated and monosaturated fatty acids increase interleukin-10 production in rat hepatocytes. Nihob Arukoru Yakubutsu Igakkai Zasshi 2007, 42:32-35.
12. Yang D.Y., Pan H.C., Yen Y.J., Wang C.C., Chuang Y.H., Chen S.Y., et al. Detrimental effects of post-treatment with fatty acids on brain injury in ischemic rats. NeuroToxicology 2007, 28:1220-1229.
13. Pan H.C., Kao T.K., Ou Y.C., Yang D.Y., Yen Y.J., Wang C.C., et al. Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J Nutr Biochem 2009, 28:715-725.
14. Kalogeropoulos N., Panagiotakos D.B., Pitsavos C., Chrysohoou C., Rousinou G., Toutouza M., et al. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta 2010, 411:584-591.
15. Schwartz E.A., Zhang W.Y., Karnik S.K., Borwege S., Anand V.R., Laine P.S., et al. Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation. Arterioscler Thromb Vasc Biol 2010, 30:802-808.
16. Nanji A.A., Zakim D., Rahemtulla A., Daly T., Miao L., Zhao S., et al. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alpha and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 1997, 26:1538-1545.
17. Nanji A.A., Jokelainen K., Tipoe G.L., Rahemtulla A., Dannenberg A.J. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. J Pharmacol Exp Ther 2001, 299:638-644.
18. Okita M., Sasagawa T., Tomioka K., Hasuda K., Ota Y., Suzuki K., et al. Habitual food intake and polyunsaturated fatty acid deficiency in liver cirrhosis. Nutrition 2002, 18:304-308.
19. Pawlosky R.J., Salem N. Development of alcoholic fatty liver and fibrosis in rhesus monkeys fed a low n-3 fatty acid diet. Alcohol Clin Exp Res 2004, 28:1569-1576.
20. Fernandez M.I., Torres M.I., Gil A., Rios A. Steatosis and collagen content in experimental liver cirrhosis are affected by dietary monounsaturated and polyunsaturated fatty acids. Scand J Gastroenterol 1997, 32:350-356.
21. Fontana L., Moreira E., Torres M.I., Periago J.L., Sánchez De Medina F., Gil A. Effects of dietary polyunsaturated fatty acids and nucleotides on tissue fatty acid profiles of rats with carbon tetrachloride-induced liver damage. Clin Nutr 1999, 18:93-101.
22. Baybutt R.C., Rosales C., Brady H., Molteni A. Dietary fish oil protects against lung and liver inflammation and fibrosis in monocrotaline treated rats. Toxicology 2002, 175:1-13.
23. Puder M., Valim C., Meisel J.A., Le H.D., de Meijer V.E., Robinson E.M., et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009, 250:395-402.
24. Carter B.A., Shulman R.J. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol 2007, 4:277-287.
25. Pan P.H., Lin S.Y., Ou Y.C., Chen W.Y., Chuang Y.H., Yen Y.J., et al. Stearic acid attenuates cholestasis-induced liver injury. Biochem Biophys Res Commun 2010, 391:1537-1542.
26. Lee S., Kim S., Le H.D., Meisel J., Strijbosch R.A.M., Nose V., et al. Reduction of hepatocellular injury after common bile duct ligation using omega-3 fatty acids. J Pediatr Surg 2008, 43:2010-2015.
27. Richard D., Bausero P., Schneider C., Visioli F. Polyunsaturated fatty acids and cardiovascular disease. Cell Mol Life Sci 2009, 66:3277-3288.
28. Chen W.Y., Chen C.J., Liao J.W., Mao F.C. Chromium attenuates hepatic damage in a rat model of chronic cholestasis. Life Sci 2009, 84:606-614.
29. Beilke L.D., Aleksunes L.M., Holland R.D., Besselsen D.G., Beger R.D., Klaassen C.D., et al. Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-induced liver injury in mice. Drug Metabol Dispos 2009, 37:1035-1045.
30. Chen C.J., Ou Y.C., Liao S.L., Chen W.Y., Chen S.Y., Wu C.W., et al. Transplantation of bone marrow stromal cells for peripheral nerve repair. Exp Neurol 2007, 204:443-453.
31. Rutenberg A.M., Kim H., Fischbein J.W., Hanker J.S., Wasserkrug H.L., Seligman A.M. Histochemical and ultrastructural demonstration of γ-glutamyl transpeptidase activity. J Histochem Cytochem 1969, 17:517-526.
32. Nagase H., Woessner J.F. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-21494.
33. Beaussier M., Wendum D., Schiffer E., Dumont S., Rev C., Lienhart A., et al. Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab Invest 2007, 87:292-303.
34. Bauer M., Schuppan D. TGF-β1 in liver fibrosis: time to change paradigms. FEBS Lett 2001, 502:1-3.
35. Gressner A.M., Weiskirchen R., Breitkopf K., Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002, 7:d793-807.
36. Fu M., Zhang J., Zhu X., Myles D.E., Willson T.M., Liu X., et al. Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J Biol Chem 2001, 276:45888-45894.
37. Kobayashi T., Inoue T., Okada H., Kikuta T., Tanno Y., Nishida T., et al. Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose. Clin Exp Nephrol 2005, 9:114-121.
38. Reyes-Gordillo K., Segovia J., Shibayama M., Tsutsumi V., Vergara P., Moreno M.G., et al. Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rat: role of TGF-β modulation and oxidative stress. Fundam Clin Pharmacol 2008, 22:417-427.
39. Dold S., Laschke M.W., Lavasani S., Menger M.D., Jeppsson B., Thorlacius H. Simvastatin protects against cholestasis-induced liver injury. Br J Pharmacol 2009, 156:466-474.
40. Chen A., Zheng S. Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-κB and ERK signaling. Br J Pharmacol 2008, 153:557-567.
41. Poli G., Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 1997, 22:287-305.
42. Zhong Z., Froh M., Lehnert M., Schoonhoven R., Yang L., Lind H., et al. Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats. Am J Physiol Gastrointest Liver Physiol 2003, 285:G1004-1013.
43. Le Jossic-Corcos C., Duclos S., Ramirez L.C., Zaghini I., Chevillard G., Martin P., et al. Effects of peroxisome proliferator-activated receptor alpha activation on pathways contributing to cholesterol homeostasis in rat hepatocytes. Biochim Biophys Acta 2004, 1683:49-58.
44. Sohma R., Takahashi M., Takada H., Takada H., Kuwayama H. Protective effect of n-3 polyunsaturated fatty acid on primary culture of rat hepatocytes. J Gastroenterol Hepatol 2007, 22:1965-1970.
45. Olaso E., Friedmann S.L. Molecular regulation of hepatic fibrogenesis. J Hepatol 1998, 29:836-847.
46. Mickleborough T.D., Tecklenburg S.L., Montgomery G.S., Lindley M.R. Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. Clin Nutr 2009, 28:71-77.
47. Williams E.J., Gaca M.D., Brigstock D.R., Arthur M.J., Benyon R.C. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. J Hepatol 2000, 32:754-761.
48. Uchio K., Graham M., Dean N.M., Rosenbaum J., Desmouliere A. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis. Wound Repair Regen 2000, 12:60-66.
49. Demirbilek S., Akm M., Gurunluoglu K., Aydm N.E., Emre M.H., Tas E., et al. The NF-κB inhibitors attenuate hepatic injury in bile duct ligated rats. Pediatr Surg Int 2006, 22:655-663.
50. Sierra S., Lara-Villoslada F., Comalada M., Olivares M., Xaus J. Dietary fish oil n-3 fatty acids increase regulatory cytokine production and exert anti-inflammatory effects in two murine models of inflammation. Lipids 2006, 41:1115-1125.
51. Schmöcker C., Weylandt K.H., Kahlke L., Wang J., Lobeck H., Tiegs G., et al. Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology 2007, 45:864-869.
52. Dinant S., Veteläinen R.L., Florquin S., van Vliet A.K., van Gulik T.M. IL-10 attenuates hepatic I/R injury and promotes hepatocyte proliferation. J Surg Res 2007, 141:176-182.
53. Baroni G.S., D'Ambrosio L., Ferretti G., Casini A., Sario A.D., Salzano R., et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 1998, 27:720-726.
54. Choi-Kwon S., Park K.A., Lee H.J., Park M.S., Lee J.H., Jeon S.E., et al. Temporal changes in cerebral antioxidant enzyme activities after ischemia and reperfusion in a rat focal brain ischemia model: effect of dietary fish oil. Brain Res Dev Brain Res 2004, 152:11-18.
55. Wei-guo Z., Hui Y., Shan L., Yun Z., Wen-cheng N., Fu-lin Y., et al. PPAR-gamma agonist inhibits Ang II-induced activation of dendritic cells via the MAPK and NF-kappaB pathways. Immunol Cell Biol 2010, 88:305-312.
56. Marra F., DeFranco R., Robino G., Novo E., Efsen E., Pastacaldi S., et al. Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. World J Gastroenterol 2005, 11:4931-4938.
57. Cindoruk M., Kerem M., Karakan T., Salman B., Akin O., Alper M., et al. Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study. BMC Gastroenterology 2007, 7:44.
58. González-Périz A., Plangumà A., Gronert K., Miquel R., López-Parra M., Titos E., et al. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J 2006, 20:2537-2539.
59. Jeong K.C., Hsu H.W., Lee J.W., Ham M., Huh J.Y., Shin H.J., Kim W.S., et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab 2009, 296:E955-964.
60. Kim Y.W., Lee S.M., Shin S.M., Hwang S.J., Brooks J.S., Kang H.E., et al. Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injury. Free Radic Biol Med 2009, 47:1082-1092.
61. Suchankova G., tekle M., Saha A.K., Ruderman N.B., Clarke S.D., Gettys T.W. Dietary polyunsaturated fatty acids enhances hepatic AMP-activated protein kinase activity in rats. Biochem Biophys Res Commun 2005, 326:851-858.
62. Lee J.Y., Plakidas A., Lee W.H., Heikkinen A., Chanmugam P., Bray G., et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 2003, 44:479-486.
63. Chen W., Jump D.B., Esselman W.J., Busik J.V. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest Ophthalmol Vis Sci 2007, 48:18-26.
64. Wakabayashi Y., Shimizu H., Kimura F., Yoshidome H., Ohtsuka M., Kato A., et al. Mechanism of neutrophil accumulation in sinusoids after extrahepatic biliary obstruction. Hepatogastroenterology 2008, 55:1179-1183.
65. Sokol R.J., Devereaux M., Khandwala R.A. Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J Lipid Res 1991, 32:1349-1357.
66. Parola M., Leonarduzzi G., Robino G., Albano E., Poli G., Dianzani M.U. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radic Biol Med 1996, 20:351-359.
67. Sokol R.J., Devereaux M.W., Khandwala R. Effect of oxypurinol, a xanthine oxidase inhibitor, on hepatic injury in the bile duct-ligated rat. Pediatr Res 1998, 44:397-401.
68. Rippe R.A., Schrum L.W., Stefanovic B., Solis-Herruzo J.A., Brenner D.A. NF-kappaB inhibits expression of the alpha1 (I) collagen gene. DNA Cell Biol 1999, 18:751-761.
69. Yuan L.Q., Lu Y., Luo X.H., Xie H., Wu X.P., Liao E.Y. Taurine promotes connective tissue growth factor (CTGF) expression in osteoblasts through the ERK signal pathway. Amino Acids 2007, 32:425-430.
70. Kefaloyianni E., Gaitanaki C., Beis I. ERK1/2 and p38-MAPK signaling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Signal 2006, 18:2238-2251.
71. Phanish M.K., Wahab N.A., Hendry B.M., Dockrell M.E. TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signaling. Nephron Exp Nephrol 2005, 100:E156-165.
72. Alpini G., Glasser S., Alvaro D., Ueno Y., Marzioni M., Francis H., et al. Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol-3-kinase-dependent pathway in rats. Gastroenterology 2002, 123:1226-1237.
73. Zhou Y., Zheng S., Lin J., Zhang Q.J., Chen A. The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro. Lab Invest 2007, 87:488-498.
74. Zuo W., Chen Y.G. Specific activation of mitogen-activated protein kinase by transforming growth factor-beta receptors in lipid rafts is required for epithelial cell plasticity. Mol Biol Cell 2009, 20:1020-1029.
75. El-Najjar N., Chatila M., Moukadem H., Vuorela H., Ocker M., Gandesiri M., et al. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis 2010, 15:183-195.
76. Antony R., Lukiw W.J., Bazan N.G. Neuroprotectin D1 induces dephosphorylation of Bcl-xL in a PP2A-dependent manner during oxidative stress and promotes retinal pigment epithelial cell survival. J Biol Chem 2010, 10.1074/jbc.M109.095232.
77. Shackelford C., Long G., Wolf J., Okerberg C., Herbert R. Qualitative and quantitative analysis of non-neoplastic lesions in toxicology studies. Toxicol Pathol 2002, 30:93-96.